APA (7th ed.) Citation

Zaza, M., Rashed, M. H., Elrefaey, H., Hassan, M. H., Abo-Salem, O. M., & El-Sayed, E. M. (2024). PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis. Canadian Journal of Physiology & Pharmacology, 102(1), 55. https://doi.org/10.1139/cjpp-2023-0031

Chicago Style (17th ed.) Citation

Zaza, Mohamed, Mohammed H. Rashed, Hesham Elrefaey, Memy H. Hassan, Osama M. Abo-Salem, and El-Sayed M. El-Sayed. "PRIMA-1 Synergizes Olaparib-induced Cell Death in P53 Mutant Triple Negative Human Breast Cancer Cell Line via Restoring P53 Function, Arresting Cell Cycle, and Inducing Apoptosis." Canadian Journal of Physiology & Pharmacology 102, no. 1 (2024): 55. https://doi.org/10.1139/cjpp-2023-0031.

MLA (9th ed.) Citation

Zaza, Mohamed, et al. "PRIMA-1 Synergizes Olaparib-induced Cell Death in P53 Mutant Triple Negative Human Breast Cancer Cell Line via Restoring P53 Function, Arresting Cell Cycle, and Inducing Apoptosis." Canadian Journal of Physiology & Pharmacology, vol. 102, no. 1, 2024, p. 55, https://doi.org/10.1139/cjpp-2023-0031.